Stéphane Bancel
Chief Executive Officer at
MODERNA, INC.
Net worth: 1 052 M $ as of 30/05/2026
Profile
Stéphane Bancel is a businessperson who has been the head of 5 different companies. Presently, he occupies the position of Chief Executive Officer & Director at Moderna, Inc., Chief Executive Officer & Director at ModernaTX, Inc. (a subsidiary of Moderna, Inc.) and Chief Executive Officer at Moderna SpA. Mr. Bancel is also on the board of 5 other companies. In his past career Stéphane Bancel occupied the position of Chairman at BG Medicine, Inc., Executive Director-Global Manufacturing Strategy at Eli Lilly & Co. Principal at Eli Lilly & Co. Ltd. and Managing Director at Eli Lilly Benelux SA (both are subsidiaries of Eli Lilly & Co.) and Chief Executive Officer for bioMérieux SA. Stéphane Bancel received a graduate degree from the University of Minnesota, a graduate degree from École Centrale Paris and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MODERNA, INC. 5.54% | 08/03/2026 | 21,963,357 ( 5.54% ) | 1 036 M $ | 30/05/2026 |
| 01/03/2026 | 1,184,989 ( 0.92% ) | 16 M $ | 30/05/2026 |
Latest news about Stéphane Bancel
Stéphane Bancel active positions
| Companies | Position | Start |
|---|---|---|
| MODERNA, INC. | Chief Executive Officer | 28/02/2011 |
| GENERATE BIOMEDICINES, INC. | Director/Board Member | 31/08/2019 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 31/12/2012 |
Moderna SpA
 Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Chief Executive Officer | - |
Qiagen SRL
 Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Director/Board Member | - |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Director/Board Member | 01/08/2020 |
Museum of Science
 Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Director/Board Member | - |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Director/Board Member | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Chief Executive Officer | - |
Former positions of Stéphane Bancel
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Stéphane Bancel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
QIAGEN NV
 QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
BG Medicine, Inc.
 BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Tafkak, Inc.
 Tafkak, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genome sequencing and analysis solutions | Commercial Services |
bioMérieux SA
 bioMérieux SA Medical SpecialtiesHealth Technology Develops biotechnological products specializing in in-vitro diagnostics and infectious diseases | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services Provides products for preanalytical sample preparation and molecular diagnostics solutions | Commercial Services |
École Centrale Paris
 École Centrale Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Eli Lilly Benelux SA
 Eli Lilly Benelux SA Pharmaceuticals: MajorHealth Technology Engages in discovery and development of medicines | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
Qiagen SRL
Qiagen SRL Medical SpecialtiesHealth Technology Provides molecular testing solutions | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Moderna SpA
Moderna SpA Food DistributorsDistribution Services Wholesales food and non-food products | Distribution Services |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Moderna Holding BV
 Moderna Holding BV MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
- Stock Market
- Insiders
- Stéphane Bancel
